All times are listed in CET (Central European Time)

Mesothelioma: Will I-O shape the future? Educational session

Surgery

Lecture Time
10:45 - 11:00
Speakers
  • E. Lim (London, United Kingdom)
Room
Channel 3
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • E. Lim (London, United Kingdom)
Novel therapeutic approaches: Exciting times in lung cancer Educational session

Antibody drug conjugates

Lecture Time
10:00 - 10:15
Speakers
  • D. Planchard (Villejuif, France)
Room
Channel 2
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • D. Planchard (Villejuif, France)
Novel therapeutic approaches: Exciting times in lung cancer Educational session

Bi-specific and tri-specific Ab

Lecture Time
10:15 - 10:30
Speakers
  • B. Cho (Seoul, Korea, Republic of)
Room
Channel 2
Date
Thu, 25.03.2021
Time
10:00 - 11:00
Authors
  • B. Cho (Seoul, Korea, Republic of)
The eternal debate in stage III Multidisciplinary Tumour Board

What is the best local treatment? Radiation therapy

Lecture Time
11:35 - 11:50
Speakers
  • M. Werner-Wasik (Philadelphia, PA, United States of America)
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • M. Werner-Wasik (Philadelphia, PA, United States of America)
The eternal debate in stage III Multidisciplinary Tumour Board

What is the best local treatment? Surgery

Lecture Time
11:20 - 11:35
Speakers
  • G. Massard (, Luxembourg)
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • G. Massard (, Luxembourg)
The eternal debate in stage III Multidisciplinary Tumour Board

Don’t forget the systemic treatment

Lecture Time
11:50 - 12:05
Speakers
  • L. Coate (Limerick, Ireland)
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Coate (Limerick, Ireland)
The eternal debate in stage III Multidisciplinary Tumour Board

IO in stage III

Lecture Time
12:05 - 12:20
Speakers
  • J. Lee (Los Angeles, CA, United States of America)
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • J. Lee (Los Angeles, CA, United States of America)
The eternal debate in stage III Multidisciplinary Tumour Board

Q&A and live discussion

Lecture Time
12:20 - 12:35
Speakers
  • A. Speakers (, Switzerland)
Room
Channel 2
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • A. Speakers (, Switzerland)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:25 - 11:31
Speakers
  • J. Wolf (Köln, Germany)
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • J. Wolf (Köln, Germany)
YO Vesalius Talk: How to run translational research studies in lung cancer? Where to start? Young oncologists

Your perspective and personal story

Lecture Time
11:31 - 11:37
Speakers
  • L. Paz-Ares (Madrid, Spain)
Room
Channel 3
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Paz-Ares (Madrid, Spain)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Presentation of case: Monotherapy or chemoimmunotherapy in PD-L1>50%?

Lecture Time
11:15 - 11:20
Speakers
  • L. Landi (Ravenna, Italy)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • L. Landi (Ravenna, Italy)
Optimal management of patients with PDL1-high advanced NSCLC Multidisciplinary Tumour Board

Options in patients with brain metastases

Lecture Time
11:20 - 11:35
Speakers
  • O. Gautschi (Luzern, Switzerland)
Room
Channel 1
Date
Thu, 25.03.2021
Time
11:15 - 12:35
Authors
  • O. Gautschi (Luzern, Switzerland)